November 21, 2025
BioAtla, Inc.
11085 Torreyana Road
San Diego, CA 92121
Re: Securities Being Registered under Registration Statement on Form S-3
Ladies and Gentlemen:
We have acted as counsel for BioAtla, Inc., a Delaware corporation (the “Company”), in connection with the offering by the Company of (i) up to $7,500,000 of shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), pursuant to Pre-Paid Advance Agreements, dated as of November 20, 2025 (the “Pre-Paid Advance Agreements” and such shares of Common Stock, the “PPA Shares”), between the Company and each of YA II PN, Ltd., a Cayman Islands exempt limited company (the “Yorkville”), Anson Investments Master Fund LP and Anson East Master Fund LP, (ii) up to an aggregate of $15,000,000 of shares of Common Stock pursuant to a Standby Equity Purchase Agreement, dated as of November 20, 2025 (the “Standby Equity Purchase Agreement” and such shares of Common Stock, the “SEPA Shares”), between the Company and Yorkville, and (iii) 243,428 shares of Common Stock pursuant to the Standby Equity Purchase Agreement (the “Commitment Shares”), in each case pursuant to a registration statement on Form S-3 (Registration Statement No. 333-269148) (the “Registration Statement”), filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”); evidence satisfactory to us that the Registration Statement became effective on January 17, 2023; the Prospectus, dated January 17, 2023, which forms a part of and is included in the Registration Statement (the “Base Prospectus”); the prospectus supplement dated November 20, 2025 filed with the Commission pursuant to Rule 424(b) of the rules and regulations of the Act relating to the issuance and sale of the PPA Shares, SEPA Shares and the Commitment Shares (collectively, the “Shares”). Except where the context requires otherwise, the Base Prospectus and the Prospectus Supplement are collectively referred to as the “Prospectus.” The Shares are to be sold by the Company in the manner described in the Registration Statement and the Prospectus and in accordance with the terms of the Pre-Paid Advance Agreements and the Standby Equity Purchase Agreement, as applicable.
In connection with rendering this opinion, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of (i) the Amended and Restated Certificate of Incorporation of the Company, as amended through the date hereof, (ii) the Amended and Restated Bylaws of the Company, as amended through the date hereof, (iii) certain resolutions of the Board of Directors of the Company, or a committee thereof, relating to the issuance, sale and registration of the Shares, (iv) the Registration Statement, (v) the Prospectus and (vi) such corporate records of the Company, certificates of public
